(Figures 3H, I) In contrast to the control group, the mice in LS and MS groups exhibited a significant decrease in interleukin-10 (IL-10) levels within their tumors (Figure 3J), potentially indicating an immune microenvironment enhancement and a partial alleviation of immunosuppression (45). Here, IL10 is linked to myeloid sarcoma.